Crypto Scenario Insights

MSTR's 'Inoculation' Sale: Strategic Flexibility or the End of the 'Never Sell' Premium?

What happened

MicroStrategy's sale of 32 BTC to fund preferred stock distributions has sparked debate over its 'never sell' commitment.

What we think

From a capital flows perspective, the direct liquidity impact of a $2.5 million Bitcoin sale is entirely negligible in a multi-billion-dollar daily market.

Read the analysis

MSTR's 'Inoculation' Sale: Strategic Flexibility or the End of the 'Never Sell' Premium?

We explain what happened and what could follow. We do not forecast prices.

Read the full analysis